CD9 molecule expressed on stromal cells is involved in osteoclastogenesis

Experimental Hematology

Volumn 27, Issue 5, 1999, Pages 853-859

  Tanio, Yasuko ^a   Yamazaki, Hidetoshi ^a   Kunisada, Takahiro ^a   Miyake, Kensuke ^b   Hayashi, Shin Ichi ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b SAGA UNIVERSITY   (Japan)

Author keywords

CD9; ODF OPGL; Osteoclast; Stromal cell

Indexed keywords

ACID PHOSPHATASE; CD9 ANTIGEN; COLONY STIMULATING FACTOR 1; TARTARIC ACID;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; MALE; MOUSE; MULTINUCLEAR CELL; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STROMA CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; B-LYMPHOCYTES; CALCITRIOL; CARRIER PROTEINS; CELL DIVISION; COCULTURE TECHNIQUES; DEXAMETHASONE; GENE EXPRESSION REGULATION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; OSTEOCLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; STROMAL CELLS;

ANIMALIA;

EID: 0032896681     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00011-9     Document Type: Article

References (42)

1. Maecker H.T., Todd S.C., Levy S. The tetraspanin superfamily. molecular facilitators FASEB J. 11:1997;428.
2. Masellis-Smith A., Shaw A.R. CD9-regulated adhesion. Anti-CD9 monoclonal antibody induce pre-B cell adhesion to bone marrow fibroblasts through de novo recognition of fibronectin. J Immunol. 152:1994;2768.
3. Anton E.S., Hadjiargyrou M., Patterson P.H., Matthew W.D. CD9 plays a role in Schwann cell migration in vitro. J Neurosci. 15:1995;584.
4. Heagy W., Duca K., Finberg R.W. Enkephalins stimulate leukimia cell migration and surface expression of CD9. J Clin Invest. 96:1995;1366.
5. Nakamura K., Iwamoto R., Mekada E. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin a3b1 at cell-cell contact sites. J Cell Biol. 129:1995;1691.
6. Rubinstein E., Le Naour F., Lagaudriere-Gesbert C., Billard M., Conjeaud H., Boucheix C. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur J Immunol. 26:1996;2657.
7. Tai X.G., Toyooka K., Yashiro Y., Abe R., Park C.S., Hamaoka T., Kobayashi M., Neben S., Fujiwara H. CD9-mediated costimulation of TCR-triggered naive T cells leads to activation followed by apoptosis. J Immunol. 159:1997;3799.
8. Oritani K., Wu X., Medina K., Hudson J., Miyake K., Gimble J.M., Burstein S.A., Kincade P.M. Antibody ligation of CD9 modifies production of myeloid cells in long-term cultures. Blood. 87:1996;2252.
9. Ash P., Loutit J.F., Townsend K.M.S. Osteoclasts derived from haematopoietic stem cells. Nature. 283:1980;669.
10. Scheven B.A.A., Visser J.W.M., Nijweide P.J. In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population. Nature. 321:1986;79.
11. Mundy G.R., Roodman G.D. Osteoclast ontogeny and function. Peck W.A. Bone mineral reseasch. 1987;Elsevier Science Publishers BV, Oxford, UK. 209p.
12. Suda T., Udagawa N., Takahashi N. Cells of bone. osteoclast generation Bilezikian J.P., Raisz L.G., Roden G.A. Principles of bone biology. 1996;Academic Press, New York. 87p.
13. Takahashi N., Udagawa N., Tanaka S., Murakami H., Owan I., Tamura T., Suda T. Postmitotic osteoclast precursors are mononuclear cells which express macrophage-associated phenotypes. Dev Biol. 163:1994;212.
14. Udagawa N., Takahashi N., Akatsu T., Tanaka H., Sasaki T., Nishihara T., Koga T., Martin T.J., Suda T. Origin of osteoclasts. mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells Proc Natl Acad Sci U S A. 87:1990;7260.
15. Yoshida H., Hayashi S.I., Kunisada T., Ogawa M., Nishikawa S., Okamura H., Sudo T., Shultz L.D., Nishikawa S.I. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature. 345:1990;442.
16. Wiktor-Jedrzejczak W., Bartocci A., Ferrante A.W. Jr., Ahmed-Ansari A., Sell K.W., Pollard J.W., Stanley E.R. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci U S A. 87:1990;4828.
17. Soriano P., Montgomery C., Geske R., Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell. 64:1991;693.
18. Wang Z.Q., Ovitt C., Grigoriadis A.E., Mohle-Steinlein U., Ruther U., Wagner E.F. Bone and haematopoietic defects in mice lacking c-fos. Nature. 360:1992;741.
19. Johnson R.S., Spiegelman B.M., Papaioannou V. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell. 71:1992;577.
20. Hodgkinson C.A., Moore K.J., Nakayama A., Steingrimsson E., Copeland N.G., Jenkins N.A., Arnheiter H. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell. 74:1993;395.
21. Tondravi M.M., McKercher S.R., Anderson K., Erdmann J.M., Quiroz M., Maki R., Teitelbaum S.L. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature. 386:1997;81.
22. Hagenaars C.E., van der Kraan A.A.M., Kawilarang de Haas E.W.M., Visser J.W.M., Nijweide P.J. Osteoclast formation from cloned pluripotent hematopoietic stem cells. Bone Miner. 6:1989;179.
23. Schneider G.B. Cellular specificity of the cure for osteopetrosis. isolation of and treatment with pluripotent hemopoietic stem cells Bone. 6:1985;241.
24. Hattersley G., Chambers T.J. Generation of osteoclasts from hemopoietic cells and a multipotential cell line in vitro. J Cell Physiol. 140:1989;478.
25. Kurihara N., Suda T., Miura Y., Nakauchi H., Kodama H., Hiura K., Hakeda Y., Kumegawa M. Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood. 74:1989;1295.
26. Hattersley G., Kerby J.A., Chambers T.J. Identification of osteoclast precursors in multilineage hemopoietic colonies. Endocrinology. 128:1991;259.
27. Yamane T., Kunisada T., Yamazaki H., Era T., Nakano T., Hayashi S.I. Development of osteoclasts from embryonic stem cells through a pathway that is c-fms, but not c-kit dependent. Blood. 90:1997;3516.
28. Udagawa N., Takahashi N., Akatsu T., Sasaki T., Yamaguchi A., Kodama H., Martin T.J., Suda T. The bone marrow-derived stromal cell line MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology. 125:1989;1805.
29. Shevde N., Anklesaria P., Greenberger J.S., Bleiberg I., Glowacki J. Stromal cell-mediated stimulation of osteoclastogenesis. Proc Soc Exp Biol Med. 205:1994;306.
30. Hayashi S.I., Miyamoto A., Yamane T., Kataoka H., Ogawa M., Sugawara S., Nishikawa S., Nishikawa S.I., Sudo T., Yamazaki H., Kunisada T. Osteoclast precursors in bone marrow and peritoneal cavity. J Cell Physiol. 170:1997;241.
31. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S.I., Tomoyasu A., Yano K., Goto M., Murakami A.et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and identical to TRANCE/RANKL. Proc Natl Acad Sci U S A. 95:1998;3597.
32. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., Elliott R., Colombero A., Elliott G., Scully S.et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:1998;165.
33. Wong B.R., Rho J., Arron J., Robinson E., Orlinick J., Chao M., Kalachikov S., Cayani E., Bartlett F.S. III, Frankel W.N., Lee S.Y., Choi Y. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-jun N-terminal kinase in T cells. J Biol Chem. 272:1997;25190.
34. Anderson D.A., Maraskovsky E., Billingsley W.L., Dougall W.C., Tometsko M.E., Roux E.R., Teepe M.C., DuBose R.F., Cosman D., Galibert L. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 390:1997;175.
35. Miyamoto A., Kunisada T., Hemmi H., Yamane T., Yasuda H., Miyake K., Yamazaki H., Hayashi S.I. Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts. Biochem Biophys Res Commun. 242:1998;703.
36. Nishikawa S.I., Ogawa M., Nishikawa S., Kunisada T., Kodama H. B lymphopoiesis on stromal cell clone. stromal cell clones acting on different stages of B cell differentiation Eur J Immunol. 18:1988;1767.
37. Yamazaki H., Kunisada T., Ishizu A., Ikeda H., Miyoshi I., Sudo T., Hayashi S.I., Yoshiki T. Promotion of early osteoclastogenesis and B lymphopoiesis in the bone marrow of transgenic rats with the env-pX gene of human T-cell lymphotropic virus type I. Oncogene. 17:1998;2955.
38. Sudo T., Ito M., Ogawa Y., Iizuka M., Kodama H., Kunisada T., Hayashi S.I., Ogawa M., Sakai K., Nishikawa S., Nishikawa S.I. Interleukin 7 production and function in stromal cell-dependent B cell development. J Exp Med. 170:1989;333.
39. Hayashi S.I., Kunisada T., Ogawa M., Sudo T., Kodama H., Suda T., Nishikawa S., Nishikawa S.I. Stepwise progression of B lineage differentiation supported by interleukin 7 and other stromal cell molecules. J Exp Med. 171:1990;1683.
40. Hayashi S.I., Witte P.L., Shultz L.D., Kincade P.W. Lymphohemopoiesis in culture is prevented by interaction with adherent bone marrow cells from mutant viable motheaten mice. J Immunol. 140:1988;2139.
41. Sudo T., Nishikawa S., Ogawa M., Kataoka H., Ohno N., Izawa A., Hayashi S.I., Nishikawa S.I. Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M. Oncogene. 11:1995;2469.
42. Ogawa M., Matsuzaki Y., Nishikawa S., Hayashi S.I., Kunisada T., Sudo T., Kina T., Nakauchi H., Nishikawa S.I. Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med. 174:1991;63.